JBHT
63
3
AN
43
-6
ALL
54
-6
HRB
42
-2
PCG
72
2
PSA
46
-2
GLW
67
3
AVGO
42
18
CCL
65
3
PSX
35
-4
O
31
-8
MTB
69
-7
NWL
58
-3
EA
46
2
CLX
51
-2
ICE
57
-5
MLM
63
2
ALLE
41
-5
LEN
30
-3
ACN
52
-4
JBHT
63
3
AN
43
-6
ALL
54
-6
HRB
42
-2
PCG
72
2
PSA
46
-2
GLW
67
3
AVGO
42
18
CCL
65
3
PSX
35
-4
O
31
-8
MTB
69
-7
NWL
58
-3
EA
46
2
CLX
51
-2
ICE
57
-5
MLM
63
2
ALLE
41
-5
LEN
30
-3
ACN
52
-4
Financhill
Back

Vanguard Growth Index Fund ETF Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Buy
62

VUG
Vanguard Growth Index Fund ETF

Last Price:
$488.34
Seasonality Move:
1.51%
Buy
78

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.73
Seasonality Move:
11.35%
Buy
62
Vanguard Growth Index Fund ETF (VUG) is a Buy

Is Vanguard Growth Index Fund ETF a Buy, Sell or Hold?

  • The current Vanguard Growth Index Fund ETF [VUG] share price is $481.93. The Score for VUG is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • VUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
78
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.35. The Score for CDTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VUG Stock Price Chart

What is Vanguard Growth Index Fund ETF's stock price today?

  • The Vanguard Growth Index Fund ETF share price today is $481.93
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VUG is experiencing slight selling pressure.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.

VUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 67.73 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: -100095 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (476.74 - 492.32) Sell
Bollinger Bands (100): (462.16 - 490.54) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 16.79 Buy
Relative Strength Index (14 RSI): 84.87 Buy
Chaikin Money Flow: 261741 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (192.91 - 237.53) Buy
Bollinger Bands (100): (54.69 - 176.45) Buy

VUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 486.12 Sell
20-day SMA: 485.89 Sell
50-day SMA: 486.54 Sell
200-day SMA: 439.12 Buy
8-day EMA: 189.29 Buy
20-day EMA: 86.88 Buy
50-day EMA: 36.82 Buy
200-day EMA: 9.48 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.19 Buy
20-day SMA: 220.08 Buy
50-day SMA: 159.67 Buy
200-day SMA: 72.77 Buy
8-day EMA: 219.95 Buy
20-day EMA: 209.45 Buy
50-day EMA: 171.39 Buy
200-day EMA: 93.26 Buy

Vanguard Growth Index Fund ETF Earnings Growth & VUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

Vanguard Growth Index Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):